家庭医生对哮喘患者口服皮质类固醇负担的认识。

Q3 Medicine
Aleksander Stepanović, Peter Kopač, Danica Rotar Pavlič
{"title":"家庭医生对哮喘患者口服皮质类固醇负担的认识。","authors":"Aleksander Stepanović, Peter Kopač, Danica Rotar Pavlič","doi":"10.5644/ama2006-124.446","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to identify when family physicians decide to prescribe oral corticosteroids (OCS) to treat asthma, to establish the factors affecting their decision, and how familiar family physicians are with the side effects of OCS.</p><p><strong>Materials and methods: </strong>A cross-sectional observational study was conducted among physicians that are members of the Slovenian Family Medicine Society.</p><p><strong>Results: </strong>The study included 122 family physicians from all 12 Slovenian regions. The great majority (86.9%) reported they had previously prescribed OCS to asthma patients. The largest share of these (45.1%) tended to prescribe a limited number of tablets, although many (42.6%) also prescribed the entire pack. Regarding the adverse effects associated with OCS, the physicians listed a range of potential problems, highlighting hyperglycemia and exacerbated diabetes, the impact on bone density, a suppressed immune system and increased risk of infection as the most common.</p><p><strong>Conclusion: </strong>In the future, it is vital to improve family physicians' awareness of when OCS may be prescribed to treat severe asthma, and to define the clinical pathway for severe asthma, which should also involve interdisciplinary collaboration.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"53 2","pages":"199-208"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626237/pdf/","citationCount":"0","resultStr":"{\"title\":\"Family Physicians' Awareness of the Burden of Oral Corticosteroids in Asthma Patients.\",\"authors\":\"Aleksander Stepanović, Peter Kopač, Danica Rotar Pavlič\",\"doi\":\"10.5644/ama2006-124.446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The objective of this study was to identify when family physicians decide to prescribe oral corticosteroids (OCS) to treat asthma, to establish the factors affecting their decision, and how familiar family physicians are with the side effects of OCS.</p><p><strong>Materials and methods: </strong>A cross-sectional observational study was conducted among physicians that are members of the Slovenian Family Medicine Society.</p><p><strong>Results: </strong>The study included 122 family physicians from all 12 Slovenian regions. The great majority (86.9%) reported they had previously prescribed OCS to asthma patients. The largest share of these (45.1%) tended to prescribe a limited number of tablets, although many (42.6%) also prescribed the entire pack. Regarding the adverse effects associated with OCS, the physicians listed a range of potential problems, highlighting hyperglycemia and exacerbated diabetes, the impact on bone density, a suppressed immune system and increased risk of infection as the most common.</p><p><strong>Conclusion: </strong>In the future, it is vital to improve family physicians' awareness of when OCS may be prescribed to treat severe asthma, and to define the clinical pathway for severe asthma, which should also involve interdisciplinary collaboration.</p>\",\"PeriodicalId\":38313,\"journal\":{\"name\":\"Acta medica academica\",\"volume\":\"53 2\",\"pages\":\"199-208\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626237/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta medica academica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5644/ama2006-124.446\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica academica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5644/ama2006-124.446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是确定家庭医生何时决定开口服皮质类固醇(OCS)治疗哮喘,确定影响他们决定的因素,以及家庭医生对OCS副作用的熟悉程度。材料和方法:一项横断面观察性研究是在斯洛文尼亚家庭医学协会成员的医生中进行的。结果:该研究包括来自斯洛文尼亚所有12个地区的122名家庭医生。绝大多数(86.9%)报告他们以前曾给哮喘患者开过OCS。其中最大的份额(45.1%)倾向于开有限数量的药片,尽管许多(42.6%)也开整包。关于与OCS相关的不良反应,医生列出了一系列潜在的问题,强调高血糖和加重糖尿病,对骨密度的影响,抑制免疫系统和增加感染风险是最常见的。结论:在未来,提高家庭医生对重症哮喘何时可开OCS的认识,明确重症哮喘的临床路径是至关重要的,这需要跨学科的合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Family Physicians' Awareness of the Burden of Oral Corticosteroids in Asthma Patients.

Objective: The objective of this study was to identify when family physicians decide to prescribe oral corticosteroids (OCS) to treat asthma, to establish the factors affecting their decision, and how familiar family physicians are with the side effects of OCS.

Materials and methods: A cross-sectional observational study was conducted among physicians that are members of the Slovenian Family Medicine Society.

Results: The study included 122 family physicians from all 12 Slovenian regions. The great majority (86.9%) reported they had previously prescribed OCS to asthma patients. The largest share of these (45.1%) tended to prescribe a limited number of tablets, although many (42.6%) also prescribed the entire pack. Regarding the adverse effects associated with OCS, the physicians listed a range of potential problems, highlighting hyperglycemia and exacerbated diabetes, the impact on bone density, a suppressed immune system and increased risk of infection as the most common.

Conclusion: In the future, it is vital to improve family physicians' awareness of when OCS may be prescribed to treat severe asthma, and to define the clinical pathway for severe asthma, which should also involve interdisciplinary collaboration.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta medica academica
Acta medica academica Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
21
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信